Effects of physicochemical properties of poly(lactide-co-glycolide) on drug release behavior of hydrophobic drug-loaded nanoparticles

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 520, Issue , 2017, Pages 771-778

  Takeuchi, Issei ^a   Tomoda, Keishiro ^a   Hamano, Ayaka ^a   Makino, Kimiko ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Activation energy; Glass transition temperature; Nanoparticle; Poly(DL lactide co glycolide); Poly(L lactide co glycolide); Rifampicin

Indexed keywords

ACTIVATION ENERGY; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL ACTIVATION; CRYSTALLINE MATERIALS; GLASS; LACTIC ACID; MONOMERS; NANOPARTICLES; ORGANIC POLYMERS; TEMPERATURE;

DRUG LOADED NANOPARTICLE; GLYCOLIDE; MONOMER COMPOSITIONS; PHOSPHATE-BUFFERED SALINES; PHYSICOCHEMICAL PROPERTY; POLY LACTIDE-CO-GLYCOLIDE; POLY(DL-LACTIDE-COGLYCOLIDE); RIFAMPICIN;

GLASS TRANSITION;

COPOLYMER; DRUG CARRIER; GLYCOLIC ACID; LACTIC ACID; MONOMER; NANOPARTICLE; PHOSPHATE BUFFERED SALINE; POLYGLACTIN; RIFAMPICIN;

ARTICLE; CHEMICAL COMPOSITION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; ENERGY; GLASS TRANSITION TEMPERATURE; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

EID: 85013885931     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2017.02.054     Document Type: Article

References (35)

1. [1] Brannon-Peppas, L., Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. 116 (1995), 1–9.
2. [2] Makadia, H.K., Siegel, S.J., Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3 (2011), 1377–1397.
3. [3] Ignatius, A.A., Claes, L.E., In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide). Biomaterials 17 (1996), 831–839.
4. [4] Tujimoto, H., Hara, K., Huang, C.C., Yokoyama, T., Yamamoto, H., Takeuchi, H., Kawashima, Y., Akagi, K., Miwa, N., Percutaneous absorption study of biodegradable PLGA nano-spheres via human skin biopsies. J. Soc. Power Technol. Japan 41 (2004), 867–875.
5. [5] Miyazaki, S., Takahashi, A., Kubo, W., Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J. Pharm. Pharm. Sci. 6 (2003), 240–245.
6. [6] Tomoda, K., Terashima, H., Suzuki, K., Inagi, T., Terada, H., Makino, K., Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf. B 88 (2011), 706–710.
7. [7] Tomoda, K., Terashima, H., Suzuki, K., Inagi, T., Terada, H., Makino, K., Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo. Colloids Surf. B 92 (2012), 50–54.
8. [8] Tomoda, K., Watanabe, A., Suzuki, K., Inagi, T., Terada, H., Makino, K., Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf. B 97 (2012), 84–89.
9. [9] Takeuchi, I., Fukuda, K., Kobayashi, S., Makino, K., Transdermal delivery of estradiol-loaded PLGA nanoparticles using iontophoresis for treatment of osteoporosis. Bio-Med. Mater. Eng. 27 (2016), 475–483.
10. [10] Tomoda, K., Kojima, S., Kajimoto, M., Watanabe, D., Nakajima, T., Makino, K., Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres. Colloids Surf. B 45 (2005), 1–6.
11. [11] Tomoda, K., Ohkoshi, T., Nakajima, T., Makino, K., Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles. Colloids Surf. B 64 (2008), 70–76.
12. [12] Tomoda, K., Ohkoshi, T., Hirota, K., Sonavane, G.S., Nakajima, T., Terada, H., Komuro, M., Kitazato, K., Makino, K., Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Colloids Surf. B 71 (2009), 177–182.
13. [13] Mu, L., Feng, S.-S., PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm. Res. 20 (2003), 1864–1872.
14. [14] Gomes, C., Moreira, R.G., Castell-Perez, E., Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications. J. Food Sci. 76 (2011), N16–N24.
15. [15] Sansdrap, P., Moës, A.J., In vitro evaluation of the hydrolytic degradation of dispersed and aggregated poly(DL-lactide-co-glycolide) microspheres. J. Control. Release 43 (1997), 47–58.
16. [16] Zolnik, B.S., Burgess, D.J., Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres. J. Control. Release 127 (2008), 137–145.
17. [17] Faisant, N., Siepmann, J., Benoit, J.P., PLGA-based microparticles: elucidation of mechanisms and a new simple mathematical model quantifying drug release. Eur. J. Pharm. Sci. 15 (2002), 355–366.
18. [18] Hu, C., Feng, H., Zhu, C., Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system. Colloids Surf. B 95 (2012), 162–169.
19. [19] Ito, F., Fujimori, H., Honnami, H., Kawakami, H., Kanamura, K., Makino, K., Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique. Colloids Surf. B 66 (2008), 65–70.
20. [20] Hirota, K., Hasegawa, T., Nakajima, T., Inagawa, H., Kohchi, C., Soma, G.-I., Makino, K., Terada, H., Delivery of rifampicin–PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J. Control. Release 142 (2010), 339–346.
21. [21] Doan, T.V.P., Couet, W., Olivier, J.C., Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int. J. Pharm. 414 (2011), 112–117.
22. [22] Ohashi, K., Kabasawa, T., Ozeki, T., Okada, H., One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. J. Control. Release 135 (2009), 19–24.
23. [23] Sung, J.C., Padilla, D.J., Garcia-Contreras, L., VerBerkmoes, J.L., Durbin, D., Peloquin, C.A., Elbert, K.J., Hickey, A.J., Edwards, D.A., Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm. Res. 26 (2009), 1847–1855.
24. [24] Dunne, M., Corrigan, O.I., Ramtoola, Z., Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21 (2000), 1659–1668.
25. [25] Zolnik, B.S., Leary, P.E., Burgess, D.J., Elevated temperature accelerated release testing of PLGA microspheres. J. Control. Release 112 (2006), 293–300.
26. [26] Wolkers, W.F., Walker, N.J., Tablin, F., Crowe, J.H., Human platelets loaded with trehalose survive freeze-drying. Cryobiology 42 (2001), 79–87.
27. [27] Fukuzaki, H., Yoshida, M., Asano, M., Kumakura, M., Imasaka, K., Nagai, T., Mashimo, T., Yuasa, H., Imai, K., Yamanaka, H., Synthesis of biodegradable copoly(L-lacticacid/aromatic hydroxyacids) with relatively low molecular weight. Eur. Polym. J. 26 (1990), 1273–1277.
28. 13C n.m.r. spectroscopy. Polymer 37 (1996), 201–203.
29. [29] Farnia, S.M.F., Mohammadi-Rovshandeh, J., Sarbolouki, M.N., Synthesis and characterization of novel biodegradable triblock copolymers from L-lactide glycolide, and PPG. J. Appl. Polym. Sci. 73 (1999), 633–637.
30. [30] Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., Gao, Z.-J., PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J. Control. Release 71 (2001), 203–211.
31. [31] Lichun, L., Charles, A.G., Antonios, G.M., In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J. Biomed. Mater. Res. 46 (1999), 236–244.
32. [32] Hirenkumar, K.M., Steven, J.S., Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymer 3 (2011), 1377–1397.
33. [33] Amann, L.C., Gandal, M.J., Lin, R., Liang, Y., Siegel, S., In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. Pharm. Res. 27 (2010), 1730–1737.
34. [34] Takeuchi, I., Tomoda, K., Nakajima, T., Terada, H., Kuroda, H., Makino, K., Estimation of crystallinity of trehalose dihydrate microspheres by usage of terahertz time-domain spectroscopy. J. Pharm. Sci. 101 (2012), 3465–3472.
35. [35] Takeuchi, I., Shimakura, K., Kuroda, H., Nakajima, T., Goto, S., Makino, K., Estimation of crystallinity of nifedipine-polyvinylpyrrolidone solid dispersion by usage of terahertz time-domain spectroscopy and of X-ray powder diffractometer. J. Pharm. Sci. 104 (2015), 4307–4313.